Biomarkers of Inflammation, Thrombogenesis, and Collagen Turnover in Patients With Atrial Fibrillation
- PMID: 29558818
- PMCID: PMC6707715
- DOI: 10.1177/1076029618761006
Biomarkers of Inflammation, Thrombogenesis, and Collagen Turnover in Patients With Atrial Fibrillation
Abstract
The purpose of this study was to determine whether there are any differences in the levels of inflammatory, thrombotic, and collagen turnover biomarkers between individuals with atrial fibrillation (AF) and healthy volunteers. Circulating plasma levels of plasminogen activator inhibitor 1 (PAI-1), CD40-ligand (CD40-L), nucleosomes (which are indicators of cell death), C-reactive protein (CRP), procollagen III N-terminal propeptide (PIIINP), procollagen III C-terminal propeptide (PIIICP), procollagen I N-terminal propeptide, tissue plasminogen activator, and von Willebrand factor were analyzed as potential biomarkers of AF. Baseline plasma was collected from patients with AF prior to ablation surgery at Loyola University Medical Center. Individuals with AF had statistically significantly increased levels of PAI-1, CD40-L, and nucleosomes, when compared to the normal population ( P < .0001). Additionally, there was a statistically significant increase in the CRP ( P = .01), PIIINP ( P = .04), and PIIICP ( P = .0008) when compared to normal individuals. From this study, it is concluded that the prothrombotic, inflammatory, and collagen turnover biomarkers PAI-1, CD40-L, nucleosomes, CRP, PIIICP, and PIIINP are elevated in AF.
Keywords: atrial fibrillation; inflammation; thrombosis.
Conflict of interest statement
Figures



Similar articles
-
Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline: The Multi-Ethnic Study of Atherosclerosis.Circ Arrhythm Electrophysiol. 2018 Oct;11(10):e006557. doi: 10.1161/CIRCEP.118.006557. Circ Arrhythm Electrophysiol. 2018. PMID: 30354407 Free PMC article.
-
Fibrinolytic Deficit and Platelet Activation in Atrial Fibrillation and Their Postablation Modulation.Clin Appl Thromb Hemost. 2018 Jul;24(5):803-807. doi: 10.1177/1076029617750270. Epub 2018 Jan 28. Clin Appl Thromb Hemost. 2018. PMID: 29374968 Free PMC article.
-
Increased Level of Thrombotic Biomarkers in Patients with Atrial Fibrillation Despite Traditional and New Anticoagulant Therapy.Clin Appl Thromb Hemost. 2016 Nov;22(8):743-748. doi: 10.1177/1076029616648407. Epub 2016 May 11. Clin Appl Thromb Hemost. 2016. PMID: 27170781 Free PMC article.
-
Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism.Curr Vasc Pharmacol. 2015;13(2):192-201. doi: 10.2174/15701611113116660165. Curr Vasc Pharmacol. 2015. PMID: 24188486 Review.
-
Inflammatory Biomarkers in Atrial Fibrillation.Curr Med Chem. 2019;26(5):837-854. doi: 10.2174/0929867324666170727103357. Curr Med Chem. 2019. PMID: 28748764 Review.
Cited by
-
The Role of Major Inflammatory Biomarkers in the Pathogenesis of Atrial Fibrillation.J Innov Card Rhythm Manag. 2022 Dec 15;13(12):5265-5277. doi: 10.19102/icrm.2022.13125. eCollection 2022 Dec. J Innov Card Rhythm Manag. 2022. PMID: 37293559 Free PMC article.
-
Dynamics of Soluble Thrombomodulin and Circulating miRNAs in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation.Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619851570. doi: 10.1177/1076029619851570. Clin Appl Thromb Hemost. 2019. PMID: 31140290 Free PMC article.
-
Atrial Fibrillation and Acute Ischemic Stroke: Evaluation of the Contemporary 2018 National Inpatient Sample Database.CJC Open. 2022 Feb 10;4(6):513-519. doi: 10.1016/j.cjco.2022.01.010. eCollection 2022 Jun. CJC Open. 2022. PMID: 35734515 Free PMC article.
-
A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation.J Clin Med. 2021 Sep 27;10(19):4430. doi: 10.3390/jcm10194430. J Clin Med. 2021. PMID: 34640448 Free PMC article. Review.
-
Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation.Int J Mol Sci. 2024 Apr 8;25(7):4109. doi: 10.3390/ijms25074109. Int J Mol Sci. 2024. PMID: 38612918 Free PMC article.
References
-
- Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104(11):1543–1549. - PubMed
-
- Collila S, Crow A, Petkun W, Singer D, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–1147. - PubMed
-
- Zhao LQ, Liu SW. Atrial fibrillation in essential hypertension: an issue of concern. J Cardiovasc Med. 2014;15(2):100–106. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous